Zobrazeno 11 - 20
of 37
pro vyhledávání: '"Martin Faehling"'
Autor:
Harald Kaemmerer, Matthias Gorenflo, Dörte Huscher, David Pittrow, Christian Apitz, Helmut Baumgartner, Felix Berger, Leonhard Bruch, Eva Brunnemer, Werner Budts, Martin Claussen, Gerry Coghlan, Ingo Dähnert, Michele D’Alto, Marion Delcroix, Oliver Distler, Sven Dittrich, Daniel Dumitrescu, Ralf Ewert, Martin Faehling, Ingo Germund, Hossein Ardeschir Ghofrani, Christian Grohé, Karsten Grossekreymborg, Michael Halank, Georg Hansmann, Dominik Harzheim, Attila Nemes, Kalman Havasi, Matthias Held, Marius M. Hoeper, Michael Hofbeck, Wolfgang Hohenfrost-Schmidt, Elena Jurevičienė, Lina Gumbienè, Hans-Joachim Kabitz, Hans Klose, Thomas Köhler, Stavros Konstantinides, Martin Köestenberger, Rainer Kozlik-Feldmann, Hans-Heiner Kramer, Cornelia Kropf-Sanchen, Astrid Lammers, Tobias Lange, Philipp Meyn, Oliver Miera, Katrin Milger-Kneidinger, Rhoia Neidenbach, Claus Neurohr, Christian Opitz, Christian Perings, Bjoern Andrew Remppis, Gabriele Riemekasten, Laura Scelsi, Werner Scholtz, Iveta Simkova, Dirk Skowasch, Andris Skride, Gerd Stähler, Brigitte Stiller, Iraklis Tsangaris, Carmine Dario Vizza, Anton Vonk Noordegraaf, Heinrike Wilkens, Hubert Wirtz, Gerhard-Paul Diller, Ekkehard Grünig, Stephan Rosenkranz
Publikováno v:
Journal of Clinical Medicine, Vol 9, Iss 5, p 1456 (2020)
Introduction: Pulmonary hypertension (PH) is a common complication in patients with congenital heart disease (CHD), aggravating the natural, post-operative, or post-interventional course of the underlying anomaly. The various CHDs differ substantiall
Externí odkaz:
https://doaj.org/article/208b2fcce4c14f418708c42008cb333f
Autor:
Mary O’Brien, Luis Paz-Ares, Sandrine Marreaud, Urania Dafni, Kersti Oselin, Libor Havel, Emilio Esteban, Dolores Isla, Alex Martinez-Marti, Martin Faehling, Masahiro Tsuboi, Jong-Seok Lee, Kazuhiko Nakagawa, Jing Yang, Ayman Samkari, Steven M Keller, Murielle Mauer, Nitish Jha, Rolf Stahel, Benjamin Besse, Solange Peters
Publikováno v:
The Lancet Oncology. 23:1274-1286
Pembrolizumab is a standard-of-care for advanced non-small-cell lung cancer (NSCLC). We assessed pembrolizumab as adjuvant therapy for completely resected stage IB-IIIA NSCLC.In this randomised, triple-blind, phase 3 trial (PEARLS/KEYNOTE-091), patie
Autor:
Hanno Leuchte, Hans-Jürgen Seyfarth, Felix Gerhardt, Stefano Barco, Philipp S. Wild, Frederikus A. Klok, Michael Halank, Stephan Rosenkranz, Marius Jankowski, Ralf Ewert, F. Joachim Meyer, Stavros Konstantinides, Mareike Lankeit, Claus Neurohr, Heinrike Wilkens, Hossein Ardeschir Ghofrani, Marius M. Hoeper, Julia Freise, Matthias Held, Luca Valerio, Martin Faehling, Ekkehard Grünig, R Wachter, Eckhard Mayer, Franziska C. Trudzinski, Kai-Helge Schmidt, Leonhard Bruch, Christian Opitz
Publikováno v:
Chest. 159:2428-2438
BACKGROUND Few data are available on the long-term course and predictors of quality of life (QoL) following acute pulmonary embolism (PE). RESEARCH QUESTION What are the kinetics and determinants of disease-specific and generic health-related QoL 3 a
Autor:
Petros Christopoulos, Klaus Kluck, Martina Kirchner, Heike Lüders, Julia Roeper, Roger-Fei Falkenstern-Ge, Marlen Szewczyk, Florian Sticht, Felix C. Saalfeld, Claas Wesseler, Björn Hackanson, Sebastian Dintner, Martin Faehling, Jonas Kuon, Melanie Janning, Diego Kauffmann-Guerrero, Daniel Kazdal, Sylke Kurz, Florian Eichhorn, Farastuk Bozorgmehr, Rajiv Shah, Amanda Tufman, Martin Wermke, Sonja Loges, Wolfgang M. Brueckl, Christian Schulz, Daniel Misch, Nikolaj Frost, Jens Kollmeier, Martin Reck, Frank Griesinger, Christian Grohé, Jin-Liern Hong, Huamao M. Lin, Jan Budczies, Albrecht Stenzinger, Michael Thomas
EGFR exon20 insertions (ex20ins) are targeted by novel compounds in non-small-cell lung cancer (NSCLC). However, data about outcome under conventional therapies and the influence of molecular features are scarce.We retrospectively analysed 118 patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d1a906745a815223c63c39691e11dd4
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/95725
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/95725
Autor:
Mary E.R. O'Brien, Luis Paz-Ares, Nitish Jha, Urania Dafni, Kersti Oselin, Libor Havel, Emilio Esteban, Dolores Isla, Alex Martinez-Marti, Martin Faehling, Masahiro Tsuboi, Jong-Seok Lee, Kazuhiko Nakagawa, Jing Yang, Steven M. Keller, Murielle Mauer, Sandrine Marreaud, Rolf A. Stahel, Benjamin Besse, Solange Peters
Publikováno v:
Journal of Clinical Oncology. 40:8512-8512
8512 Background: At the second interim analysis (IA2) of the triple-blind, phase 3 PEARLS/KEYNOTE-091 study (NCT02504372), pembrolizumab significantly improved DFS compared with placebo in patients (pts) with completely resected stage IB (T ≥4 cm)
Autor:
Ekkehard Gruenig, Luca Valerio, M Halank, Julia Freise, Felix Gerhardt, Stephan Rosenkranz, Stavros Konstantinides, Stefano Barco, R Ewert, Marius Jankowski, Mareike Lankeit, Leonhard Bruch, Martin Faehling, M Held, H Ardeschir Ghofrani
Publikováno v:
European Heart Journal. 41
Background Few data are available on the long-term course and predictors of quality of life (QoL) after acute pulmonary embolism (PE). Aims To evaluate the kinetics and determinants of QoL at 3 and 12 months after acute PE. Methods The Follow-Up afte
Autor:
Nikolaj Frost, Petros Christopoulos, Diego Kauffmann-Guerrero, Jan Stratmann, Richard Riedel, Monica Schaefer, Jürgen Alt, Sylvia Gütz, Daniel C. Christoph, Eckart Laack, Martin Faehling, Richard Fischer, Klaus Fenchel, Sebastian Haen, Lukas Heukamp, Christian Schulz, Frank Griesinger
Publikováno v:
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Introduction: We report on the results of the German early access program (EAP) with the third-generation ALK- and ROS1-inhibitor lorlatinib. Patients and Methods: Patients with documented treatment failure of all approved ALK/ROS1-specific therapies
Autor:
Wolfgang Hohenfrost-Schmidt, Felix Berger, Hans-Heiner Kramer, Ingo Germund, Eva Brunnemer, Claus Neurohr, Kálmán Havasi, Bjoern Andrew Remppis, Michele D'Alto, Marius M. Hoeper, David Pittrow, Marion Delcroix, Michael Hofbeck, Christian Perings, Rhoia Neidenbach, Werner Scholtz, Tobias Lange, Oliver Distler, Gerhard-Paul Diller, Karsten Grossekreymborg, Christian Opitz, Heinrike Wilkens, Philipp Meyn, Rainer Kozlik-Feldmann, Sven Dittrich, Lina Gumbiene, Martin Claussen, Brigitte Stiller, Gabriele Riemekasten, Elena Jurevičienė, Helmut Baumgartner, Hubert Wirtz, Laura Scelsi, Cornelia Kropf-Sanchen, Attila Nemes, Leonhard Bruch, Ralf Ewert, Hans Klose, Iraklis Tsangaris, Dörte Huscher, Christian Grohé, Werner Budts, Katrin Milger-Kneidinger, Matthias Gorenflo, Dirk Skowasch, Gerd Stähler, Anton Vonk Noordegraaf, Michael Halank, Iveta Simkova, Oliver Miera, Andris Skride, Christian Apitz, Harald Kaemmerer, TC Köhler, Daniel Dumitrescu, Ingo Dähnert, Martin Koestenberger, Gerry Coghlan, Hossein Ardeschir Ghofrani, Stavros Konstantinides, Carmine Dario Vizza, Astrid E. Lammers, Stephan Rosenkranz, Martin Faehling, Ekkehard Grünig, Matthias Held, Dominik Harzheim, Georg Hansmann, Hans-Joachim Kabitz
Publikováno v:
Journal of Clinical Medicine
Volume 9
Issue 5
Journal of Clinical Medicine, Vol 9, Iss 1456, p 1456 (2020)
Journal of clinical medicine, Basel : MDPI, 2020, vol. 9, no. 5, art. no. 1456, p. [1-21]
Kaemmerer, H, Gorenflo, M, Huscher, D R, Pittrow, D, Apitz, C, Baumgartner, H, Berger, F, Bruch, L, Brunnemer, E, Budts, W, Claussen, M, Coghlan, G, Dähnert, I, D’alto, M, Delcroix, M, Distler, O, Dittrich, S, Dumitrescu, D, Ewert, R, Faehling, M, Germund, I, Ghofrani, H A, Grohé, C, Grossekreymborg, K, Halank, M, Hansmann, G, Harzheim, D, Nemes, A, Havasi, K, Held, M, Hoeper, M M, Hofbeck, M, Hohenfrost-Schmidt, W, Jurevičienė, E, Gumbienè, L, Kabitz, H-J, Klose, H, Köhler, T, Konstantinides, S, Köestenberger, M, Kozlik-Feldmann, R, Kramer, H-H, Kropf-Sanchen, C, Lammers, A, Lange, T, Meyn, P, Miera, O, Milger-Kneidinger, K, Neidenbach, R, Neurohr, C, Opitz, C, Perings, C, Remppis, B A, Riemekasten, G, Scelsi, L, Scholtz, W, Simkova, I, Skowasch, D, Skride, A, Stähler, G, Stiller, B, Tsangaris, I, Vizza, C D, Noordegraaf, A V, Wilkens, H, Wirtz, H, Diller, G-P, Grünig, E & Rosenkranz, S 2020, ' Pulmonary hypertension in adults with congenital heart disease: Real-world data from the international compera-chd registry ', Clinical Chemistry, vol. 9, no. 5, 1456 . https://doi.org/10.3390/jcm9051456
Clinical Chemistry, 9(5):1456
Volume 9
Issue 5
Journal of Clinical Medicine, Vol 9, Iss 1456, p 1456 (2020)
Journal of clinical medicine, Basel : MDPI, 2020, vol. 9, no. 5, art. no. 1456, p. [1-21]
Kaemmerer, H, Gorenflo, M, Huscher, D R, Pittrow, D, Apitz, C, Baumgartner, H, Berger, F, Bruch, L, Brunnemer, E, Budts, W, Claussen, M, Coghlan, G, Dähnert, I, D’alto, M, Delcroix, M, Distler, O, Dittrich, S, Dumitrescu, D, Ewert, R, Faehling, M, Germund, I, Ghofrani, H A, Grohé, C, Grossekreymborg, K, Halank, M, Hansmann, G, Harzheim, D, Nemes, A, Havasi, K, Held, M, Hoeper, M M, Hofbeck, M, Hohenfrost-Schmidt, W, Jurevičienė, E, Gumbienè, L, Kabitz, H-J, Klose, H, Köhler, T, Konstantinides, S, Köestenberger, M, Kozlik-Feldmann, R, Kramer, H-H, Kropf-Sanchen, C, Lammers, A, Lange, T, Meyn, P, Miera, O, Milger-Kneidinger, K, Neidenbach, R, Neurohr, C, Opitz, C, Perings, C, Remppis, B A, Riemekasten, G, Scelsi, L, Scholtz, W, Simkova, I, Skowasch, D, Skride, A, Stähler, G, Stiller, B, Tsangaris, I, Vizza, C D, Noordegraaf, A V, Wilkens, H, Wirtz, H, Diller, G-P, Grünig, E & Rosenkranz, S 2020, ' Pulmonary hypertension in adults with congenital heart disease: Real-world data from the international compera-chd registry ', Clinical Chemistry, vol. 9, no. 5, 1456 . https://doi.org/10.3390/jcm9051456
Clinical Chemistry, 9(5):1456
Introduction: Pulmonary hypertension (PH) is a common complication in patients with congenital heart disease (CHD), aggravating the natural, post-operative, or post-interventional course of the underlying anomaly. The various CHDs differ substantiall
Die mittlerweile 3. Auflage dieser Publikation möchte die Spiroergometrie als globalen Test der kardiopulmonalen, aber auch muskulären Leistungsfähigkeit einer breiteren Anwenderschaft zugänglich machen. Die didaktische Aufbereitung wurde weiter
Autor:
F. Heinzelmann, S. Fallscheer, Jörn Sträter, R. Saetzler, H. Witte, Martin Faehling, A. Türk, S. Eschmann
Publikováno v:
Journal of Thoracic Oncology. 16:S739